1. Home
  2. LPA vs CYBN Comparison

LPA vs CYBN Comparison

Compare LPA & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPA
  • CYBN
  • Stock Information
  • Founded
  • LPA 2013
  • CYBN 2019
  • Country
  • LPA United States
  • CYBN Canada
  • Employees
  • LPA N/A
  • CYBN 50
  • Industry
  • LPA
  • CYBN Pharmaceuticals and Biotechnology
  • Sector
  • LPA
  • CYBN Health Care
  • Exchange
  • LPA Nasdaq
  • CYBN Nasdaq
  • Market Cap
  • LPA 196.1M
  • CYBN 176.5M
  • IPO Year
  • LPA N/A
  • CYBN N/A
  • Fundamental
  • Price
  • LPA $6.33
  • CYBN $7.49
  • Analyst Decision
  • LPA
  • CYBN Strong Buy
  • Analyst Count
  • LPA 0
  • CYBN 3
  • Target Price
  • LPA N/A
  • CYBN $85.00
  • AVG Volume (30 Days)
  • LPA 13.0K
  • CYBN 371.4K
  • Earning Date
  • LPA 08-13-2025
  • CYBN 08-13-2025
  • Dividend Yield
  • LPA N/A
  • CYBN N/A
  • EPS Growth
  • LPA N/A
  • CYBN N/A
  • EPS
  • LPA 0.22
  • CYBN N/A
  • Revenue
  • LPA $45,924,457.00
  • CYBN N/A
  • Revenue This Year
  • LPA N/A
  • CYBN N/A
  • Revenue Next Year
  • LPA N/A
  • CYBN N/A
  • P/E Ratio
  • LPA $29.81
  • CYBN N/A
  • Revenue Growth
  • LPA 6.18
  • CYBN N/A
  • 52 Week Low
  • LPA $5.71
  • CYBN $4.81
  • 52 Week High
  • LPA $15.85
  • CYBN $13.88
  • Technical
  • Relative Strength Index (RSI)
  • LPA 49.93
  • CYBN 51.59
  • Support Level
  • LPA $6.21
  • CYBN $6.36
  • Resistance Level
  • LPA $6.56
  • CYBN $7.88
  • Average True Range (ATR)
  • LPA 0.34
  • CYBN 0.38
  • MACD
  • LPA 0.06
  • CYBN 0.08
  • Stochastic Oscillator
  • LPA 52.10
  • CYBN 74.27

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

Share on Social Networks: